Study on correlation of genetic polymorphism of cytochrome P4502D6 with resperidone metabolism

Qian XIANG,Xia ZHAO,Ying ZHOU,Pei-hong SUN,Yan LIANG,Jing-li DUAN,Yi-in CUI
DOI: https://doi.org/10.3969/j.issn.1001-6821.2009.01.005
2009-01-01
Abstract:Objective To study the relationship of the CYP2D6*10 genetic polymorphisms and the pharmacokinetic of risperidone in Chinese healthy volunteers.Methods Two milligram of risperidone was orally administered to 23 healthy Chinese subjects,and blood samples were taken after dosing.The polymorphic alleles of CYP2D6*10 in each subject were determined.The whole blood concentration of risperidone and 9-hydroxyrisperidone were measured by an high performance liquid chromatography/tandem mass spectrometry.Results Risperidone AUC0-∞ significantly increased 811% and 212%,in subjects expressing the CYP2D6* 10 /* 10 and *1 /*10 genotypes compared with *1/*1 subjects.The mean AUC0-∞ of risperidone and the ratio of risperidone/9-hydroxyrisperidone were significantly higher in the subjects with the CYP2D6*10 /*10 allele than those with the CYP2D6*1/*1,*1/*10 genotype(P< 0.001).Conclusion CYP2D6 activity was significantly reduced in *10 homozygotes compared with *1/*10 heterozygotes and *1 homozygotes,therefore the exposure of risperidone was significantly high in CYP2D6*10/*10 carriers.
What problem does this paper attempt to address?